Sukegawa Toshiyuki
Nippon Ganka Gakkai Zasshi. 2014 Feb;118(2):111-5.
We report a patient who developed allergic contact dermatitis after using a purified sodium hyaluronate ophthalmic solution (Hyalein Mini) recognized as being extremely safe.
A 67-year-old woman presented to our hospital with a chief complaint of poor visual acuity. She had dry eye, cataract and ptosis in both eyes, and underwent crystalline lens reconstruction and ptosis surgery in both eyes. Postoperatively, her dry eye showed exacerbation and she developed Sjögren's syndrome. Keratoconjunctival epithelial disorders were controllable with lacrimal punctum plugs, Hyalein Mini and 0.1% fluorometholone ophthalmic suspension. The patient, however, repeatedly developed blepharitis, and allergic contact dermatitis was diagnosed with a positive patch test to epsilon-aminocaproic acid, an excipient in Hyalein Mini. Since switching to an ophthalmic solution without epsilon-aminocaproic acid, the allergic contact dermatitis has not recurred.
When the same ophthalmic solution is used for chronic disease for a long time, it should be noted that allergic contact dermatitis may develop.
我们报告了一名患者,在使用一种被认为极其安全的纯化透明质酸钠眼药水(Hyalein Mini)后发生了过敏性接触性皮炎。
一名67岁女性因视力差为主诉前来我院就诊。她双眼患有干眼症、白内障和上睑下垂,并接受了双眼晶状体重建和上睑下垂手术。术后,她的干眼症加重,并发干燥综合征。角结膜上皮疾病可通过泪小点塞、Hyalein Mini和0.1%氟米龙滴眼液控制。然而,该患者反复发生睑缘炎,通过对Hyalein Mini中的辅料ε-氨基己酸进行斑贴试验呈阳性,诊断为过敏性接触性皮炎。自改用不含ε-氨基己酸的眼药水后,过敏性接触性皮炎未再复发。
长期使用同一种眼药水治疗慢性病时,应注意可能发生过敏性接触性皮炎。